Covered recipient · General Payments record
JENNIFER KUO
Allopathic & Osteopathic Physicians Urology
General Payments · PY2018–2024
$34,314.78
- Reported across 51 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $316.69 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $46.14 | 3 |
| UROGEN PHARMA, INC. | $45.31 | 2 |
| COLOPLAST CORP | $39.39 | 2 |
| Axonics Modulation Technologies, Inc. | $36.21 | 2 |
| 180 Medical, Inc. | $26.91 | 1 |
| Merck Sharp & Dohme Corporation | $26.67 | 1 |
| Sumitomo Pharma America, Inc. | $25.42 | 1 |
| Tempus AI, Inc | $22.24 | 1 |
| Photocure Inc | $17.13 | 1 |
| Acerta Pharma LLC | $16.83 | 1 |
| Endo Pharmaceuticals Inc. | $14.44 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| 180 Medical, Inc. | $26.91 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151364335 | CMS |
| ABBVIE INC. | $15.13 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104119364 | CMS |
| ABBVIE INC. | $17.06 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104119366 | CMS |
| ABBVIE INC. | $13.95 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104119368 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.83 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104450112 | CMS |
| Axonics, Inc. | $21.73 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142385186 | CMS |
| Axonics, Inc. | $14.48 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142385202 | CMS |
| COLOPLAST CORP | $16.51 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117463269 | CMS |
| COLOPLAST CORP | $22.88 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117463267 | CMS |
| Endo Pharmaceuticals Inc. | $14.44 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137015454 | CMS |
| Merck Sharp & Dohme LLC | $26.67 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141810518 | CMS |
| Photocure Inc | $17.13 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119774854 | CMS |
| Sumitomo Pharma America, Inc. | $25.42 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148877752 | CMS |
| Tempus AI, Inc | $22.24 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150168076 | CMS |
| UROGEN PHARMA, INC. | $18.05 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137925898 | CMS |
| UROGEN PHARMA, INC. | $27.26 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137932500 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.